John F. Sullivan - 30 Aug 2021 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Reporting relationship: VP of Quality & Engineering
Issuer ticker: TMDX
Reported as of: 30 Aug 2021
Net transaction value: +$896
SEC form: 4
Accepted by SEC: 01 Sep 2021, 17:04:44 UTC
Source filing: View source filing
Reporting owner signature: By: /s/ Stephen Gordon, Attorney-in-Fact

Key filing fact

John F. Sullivan filed Form 4 for TransMedics Group, Inc. (TMDX) on 01 Sep 2021.

Key facts

This page summarizes John F. Sullivan's Form 4 filing for TransMedics Group, Inc. (TMDX).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 01 Sep 2021, 17:04.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: +$896.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TMDX transaction

Common Stock

Options Exercise

Transaction value: $896
Shares: +3,200
Change %: +29%
Price: $0.2800^*
Shares after: 14,273
Date: 30 Aug 2021
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TMDX transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -3,200
Change %: -17%
Price: $0.000000
Shares after: 15,772
Date: 30 Aug 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,200
Exercise price: $0.2800
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Includes 245 shares acquired under the TransMedics Group, Inc. 2019 Employee Stock Purchase Plan.

Footnote F2

The option is fully vested.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .